Telemedicine and home spirometry in cystic fibrosis: A prospective multicenter study
Pediatric Pulmonology · 2024
DOI: 10.1002/ppul.27166 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Pediatric Pulmonology, 2024. Verfasst von Jakob Medbo und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Institute of Clinical Science at Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. Hauptthemen laut MEDLINE: Cystic Fibrosis, Spirometry, Telemedicine. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Petter Silverskiolds foundation, VINNOVA.
Abstract (Originalsprache)
Objectives
Telehealth and home spirometry feasibility for children has been established, but their impact on cystic fibrosis (CF) disease progression remains unassessed. We aimed to evaluate the effects of telehealth and home spirometry on CF disease progression and care.
Methods
Children with CF aged 5–17 years from all Swedish CF centers were provided with home spirometers. A minimum of two in‐person visits were replaced with telemedicine visits and participants were instructed to conduct home spirometry before visits. Linear mixed‐effects models were used to compare annual CF disease trajectories during the intervention period and prepandemic period (1 January 2019 to 28 February 2020). Participants and caregivers completed study questionnaires.
Results
A total of 59 individuals completed the study over a mean (SD) period of 6.8 (1.4) months, made 3.1 (1.0) physical visits and 2.2 (0.6) telehealth visits per patient year during the study period. The mean difference (95% CI) between the intervention and prepandemic period progression rate for FEV 1 %, lung clearance index and BMI were −0.4 (−1.3 to 0.5, p = 0.39), 0.11 (−0.07 to 0.28, p = 0.25) and −0.02 (−0.13 to 0.08, p = 0.70), respectively. There were no major shifts in the incidence of airway pathogens, sputum cultures, or antibiotics use between the periods ( p > 0.05). The intervention did not increase stress. Almost all participants and caregivers expressed a desire to continue with home spirometry and telemedicine.
Conclusion
Combining telehealth and physical visits with access to home spirometry demonstrated comparable effectiveness as exclusively in‐person care with enhanced flexibility and personalization of CF care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatrics, Institute of Clinical Science at Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
- Department of Pediatrics, Queen Silvia's Children Hospital, Gothenburg, Sweden.
- Statistiska Konsultgruppen, Gothenburg, Sweden.
- Department of Pediatrics, Lund CF Centre, Skåne University Hospital, Lund, Sweden.
- Department of Pediatrics, Uppsala CF Centre, Uppsala University Hospital, Uppsala, Sweden.
- Stockholm CF Centre, Karolinska University Hospital Huddinge, Stockholm, Sweden.
ORCID-Profile: Jakob Medbo, Marcus Svedberg
Förderung
- Petter Silverskiolds foundation
- VINNOVA
Zitieren
APA
Medbo, J., Imberg, H., Hansen, C., Krantz, C., de Monestrol, I., & Svedberg, M. (2024). Telemedicine and home spirometry in cystic fibrosis: A prospective multicenter study. Pediatric Pulmonology. https://doi.org/10.1002/ppul.27166
Vancouver
Medbo J, Imberg H, Hansen C, Krantz C, de Monestrol I, Svedberg M. Telemedicine and home spirometry in cystic fibrosis: A prospective multicenter study. Pediatric Pulmonology. 2024. doi:10.1002/ppul.27166
BibTeX
@article{Medbo2024,
author = {Medbo, Jakob and Imberg, Henrik and Hansen, Christine and Krantz, Christina and de Monestrol, Isabelle and Svedberg, Marcus},
title = {Telemedicine and home spirometry in cystic fibrosis: A prospective multicenter study},
journal = {Pediatric Pulmonology},
year = {2024},
doi = {10.1002/ppul.27166}
}
EUVIMED